DOI QR코드

DOI QR Code

Elective splenectomy in patients with non-Hodgkin lymphoma: Does the size of the spleen affect surgical outcomes?

  • Davide Di Mauro (Department of Upper Gastrointestinal Surgery, Royal Devon and Exeter NHS Foundation Trust) ;
  • Mariannita Gelsomino (Department of Medicine, Gemelli University Hospital) ;
  • Angelica Fasano (Department of Surgery, Hospital Tor Vergata Roma) ;
  • Shahjehan Wajed (Department of Upper Gastrointestinal Surgery, Royal Devon and Exeter NHS Foundation Trust) ;
  • Antonio Manzelli (Department of Upper Gastrointestinal Surgery, Royal Devon and Exeter NHS Foundation Trust)
  • Received : 2021.09.24
  • Accepted : 2021.10.19
  • Published : 2022.05.31

Abstract

Backgrounds/Aims: Splenectomy in patients with non-Hodgkin lymphoma (NHL) is performed to relieve abdominal symptoms, treat hypersplenism or confirm diagnosis. Excision of a very large spleen is technically challenging and data on outcomes of surgery in patients with NHL are scanty. The aim of study was to evaluate the impact of spleen size on the surgical outcome of splenectomy in patients with NHL. Methods: Patients with NHL who underwent splenectomy, between 2006 and 2017, were included and divided into two groups: group 1, spleen ≤ 20 cm; group 2, spleen > 20 cm. Surgical approach, operative time, postoperative morbidity, mortality, hospital stay and re-admission rates were retrospectively compared between groups. Non-parametric data were evaluated with the Mann-Whitney U test. Differences in frequencies were analyzed with Fisher's exact test. Results: Sixteen patients were included (group 1, 6; group 2, 10). Laparoscopy was successful in three patients of group 1, none of group 2 (p = 0.035), the intraoperative time did not differ significantly between groups. One patient in each group developed postoperative complications. The patient in group 1 died of pneumonia. Median length of stay was 8 days (range, 3-16 days) for group 1, 5.5 days (range, 3-10 days) for group 2, showing no significant difference between the two groups. No patient was readmitted to hospital. Conclusions: Spleen size does not affect the outcome of splenectomy in patients with NHL. If a mini-invasive approach is to be chosen, laparoscopy may not be feasible when the spleen size is > 20 cm.

Keywords

References

  1. Xiros N, Economopoulos T, Christodoulidis C, Dervenoulas J, Papageorgiou E, Mellou S, et al. Splenectomy in patients with malignant non-Hodgkin's lymphoma. Eur J Haematol 2000;64:145-150.
  2. Brodsky J, Abcar A, Styler M. Splenectomy for non-Hodgkin's lymphoma. Am J Clin Oncol 1996;19:558-561.
  3. Walsh RM, Heniford BT. Laparoscopic splenectomy for non-Hodgkin lymphoma. J Surg Oncol 1999;70:116-121.
  4. Horowitz J, Smith JL, Weber TK, Rodriguez-Bigas MA, Petrelli NJ. Postoperative complications after splenectomy for hematologic malignancies. Ann Surg 1996;223:290-296.
  5. Edgren G, Almqvist R, Hartman M, Utter GH. Splenectomy and the risk of sepsis: a population-based cohort study. Ann Surg 2014;260:1081-1087.
  6. Bickenbach KA, Gonen M, Labow DM, Strong V, Heaney ML, Zelenetz AD, et al. Indications for and efficacy of splenectomy for haematological disorders. Br J Surg 2013;100:794-800.
  7. Balague C, Targarona EM, Cerdan G, Novell J, Montero O, Bendahan G, et al. Long-term outcome after laparoscopic splenectomy related to hematologic diagnosis. Surg Endosc 2004;18:1283-1287.
  8. Uranues S, Alimoglu O. Laparoscopic surgery of the spleen. Surg Clin North Am 2005;85:75-90, ix.
  9. Lewis KM, Li Q, Jones DS, Corrales JD, Du H, Spiess PE, et al. Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents. Surgery 2017;161:771-781.
  10. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
  11. Lemaire J, Rosiere A, Bertrand C, Bihin B, Donckier JE, Michel LA. Surgery for massive splenomegaly. BJS Open 2017;1:11-17.
  12. Saboo SS, Krajewski KM, O'Regan KN, Giardino A, Brown JR, Ramaiya N, et al. Spleen in haematological malignancies: spectrum of imaging findings. Br J Radiol 2012;85:81-92.
  13. Grahn SW, Alvarez J 3rd, Kirkwood K. Trends in laparoscopic splenectomy for massive splenomegaly. Arch Surg 2006;141:755-761.
  14. Targarona EM, Balague C, Trias M. Laparoscopic splenectomy for splenomegaly. Probl Gen Surg 2002;19:58-64.
  15. Delpero JR, Houvenaeghel G, Gastaut JA, Orsoni P, Blache JL, Guerinel G, et al. Splenectomy for hypersplenism in chronic lymphocytic leukaemia and malignant non-Hodgkin's lymphoma. Br J Surg 1990;77:443-449.
  16. Walsh RM, Brody F, Brown N. Laparoscopic splenectomy for lymphoproliferative disease. Surg Endosc 2004;18:272-275.
  17. Tsamalaidze L, Stauffer JA, Permenter SL, Asbun HJ. Laparoscopic splenectomy for massive splenomegaly: does size matter? J Laparoendosc Adv Surg Tech A 2017;27:1009-1014.
  18. Klingler PJ, Tsiotos GG, Glaser KS, Hinder RA. Laparoscopic splenectomy: evolution and current status. Surg Laparosc Endosc 1999;9:1-8.
  19. Habermalz B, Sauerland S, Decker G, Delaitre B, Gigot JF, Leandros E, et al. Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2008;22:821-848.
  20. Knauer EM, Ailawadi G, Yahanda A, Obermeyer RJ, Millie MP, Ojeda H, et al. 101 laparoscopic splenectomies for the treatment of benign and malignant hematologic disorders. Am J Surg 2003;186:500-504.
  21. Bagrodia N, Button AM, Spanheimer PM, Belding-Schmitt ME, Rosenstein LJ, Mezhir JJ. Morbidity and mortality following elective splenectomy for benign and malignant hematologic conditions: analysis of the American College of Surgeons National Surgical Quality Improvement Program data. JAMA Surg 2014;149:1022-1029.
  22. Kavic SM, Segan RD, Park AE. Laparoscopic splenectomy in the elderly: a morbid procedure? Surg Endosc 2005;19:1561-1564.
  23. Targarona EM, Espert JJ, Cerdan G, Balague C, Piulachs J, Sugranes G, et al. Effect of spleen size on splenectomy outcome. A comparison of open and laparoscopic surgery. Surg Endosc 1999;13:559-562.
  24. Ohta M, Nishizaki T, Matsumoto T, Shimabukuro R, Sasaki A, Shibata K, et al. Analysis of risk factors for massive intraoperative bleeding during laparoscopic splenectomy. J Hepatobiliary Pancreat Surg 2005;12:433-437.
  25. Wysocki M, Radkowiak D, Zychowicz A, Rubinkiewicz M, Kulawik J, Major P, et al. Prediction of technical difficulties in laparoscopic splenectomy and analysis of risk factors for postoperative complications in 468 cases. J Clin Med 2018;7:547.